Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)

NCT01120834 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: azacytidine
DRUG: vorinostat

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]
[object Object]